45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,988
Insurances with rates
2
CPT / HCPCS codes
13,335
Source MRF
Most expensive procedures (gross)
J2326
$741,229
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION
Gross
$1,482,459
J0801
$232,183
CORTICOTROPIN 80 UNIT/ML INJECTION GEL
Gross
$464,366
C9293
$221,323
GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION
Gross
$442,646
J9228
$164,253
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$328,506
J9269
$156,150
TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION
Gross
$312,299
J9348
$140,117
NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION
Gross
$280,233
J2350
$110,958
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$221,915
J9274
$94,745
TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION
Gross
$189,490
J1303
$92,822
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION
Gross
$185,645
J9334
$86,475
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN
Gross
$172,951
J9266
$86,056
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$172,113
J0202
$81,601
ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION
Gross
$163,202
J1304
$76,869
TOFERSEN 100 MG/15 ML (6.7 MG/ML) INTRATHECAL SOLUTION
Gross
$153,737
J3357
$75,994
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$151,989
J9298
$69,953
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$139,906
J9043
$66,434
CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION
Gross
$132,868
J1305
$65,198
EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION
Gross
$130,395
J2329
$59,729
UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION
Gross
$119,458
J9382
$54,947
ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$109,894
J2840
$54,891
SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION
Gross
$109,783
J2427
$54,709
PALIPERIDONE PALMITATE (3 MONTH) 819 MG/2.63 ML INTRAMUSCULAR SYRINGE
Gross
$109,419
J9272
$54,574
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION
Gross
$109,148
J9307
$54,420
PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$108,840
J0222
$52,607
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$105,214
J0584
$50,389
BUROSUMAB-TWZA 30 MG/ML SUBCUTANEOUS SOLUTION
Gross
$100,778
J3263
$49,965
TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION
Gross
$99,930
J9119
$49,081
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION
Gross
$98,163
J2323
$45,903
NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION
Gross
$91,805
J2997
$45,895
ALTEPLASE 100 MG INTRAVENOUS SOLUTION
Gross
$91,791
J1930
$43,581
LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE
Gross
$87,161
J9301
$39,859
OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION
Gross
$79,718
J9022
$36,453
ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$72,906
J9210
$35,916
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION
Gross
$71,833
J9063
$35,666
MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION
Gross
$71,331
J1323
$34,970
ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION
Gross
$69,940
J9332
$33,286
EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION
Gross
$66,572
J9333
$32,938
ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION
Gross
$65,876
J9306
$31,570
PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION
Gross
$63,140
J1932
$31,306
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$62,612
J1299
$30,194
ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION
Gross
$60,388
J0517
$27,814
BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE
Gross
$55,627
J2267
$27,029
MIRIKIZUMAB-MRKZ 100 MG/ML SUBCUTANEOUS PEN INJECTOR
Gross
$54,058
J9271
$26,767
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION
Gross
$53,534
J9038
$25,409
AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION
Gross
$50,819
J2506
$24,166
PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR
Gross
$48,332
J3315
$23,852
TRIPTORELIN PAMOATE 22.5 MG IM SUSPENSION
Gross
$47,704
J9227
$22,214
ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION
Gross
$44,427
J9204
$21,710
MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION
Gross
$43,420
J0739
$21,648
CABOTEGRAVIR ER 600 MG/3 ML (200 MG/ML) IM SUSPENSION,EXTENDED RELEASE
Gross
$43,296
A9517
$21,094
SODIUM IODIDE-131 (I-131) 500 MCI/0.5 ML ORAL KIT (THERAPEUTIC)
Gross
$42,188
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2326 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $1,482,459 | $741,229 | — | — | 1 |
| J0801 | CORTICOTROPIN 80 UNIT/ML INJECTION GEL | $464,366 | $232,183 | — | — | 0 |
| C9293 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $442,646 | $221,323 | — | — | 0 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $328,506 | $164,253 | — | — | 1 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $312,299 | $156,150 | — | — | 1 |
| J9348 | NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION | $280,233 | $140,117 | — | — | 1 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $221,915 | $110,958 | — | — | 1 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $189,490 | $94,745 | — | — | 1 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $185,645 | $92,822 | — | — | 2 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN | $172,951 | $86,475 | — | — | 1 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $172,113 | $86,056 | — | — | 1 |
| J0202 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $163,202 | $81,601 | — | — | 1 |
| J1304 | TOFERSEN 100 MG/15 ML (6.7 MG/ML) INTRATHECAL SOLUTION | $153,737 | $76,869 | — | — | 1 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE | $151,989 | $75,994 | — | — | 1 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $139,906 | $69,953 | — | — | 1 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $132,868 | $66,434 | — | — | 2 |
| J1305 | EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION | $130,395 | $65,198 | — | — | 2 |
| J2329 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $119,458 | $59,729 | — | — | 1 |
| J9382 | ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION | $109,894 | $54,947 | — | — | 3 |
| J2840 | SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION | $109,783 | $54,891 | — | — | 1 |
| J2427 | PALIPERIDONE PALMITATE (3 MONTH) 819 MG/2.63 ML INTRAMUSCULAR SYRINGE | $109,419 | $54,709 | — | — | 1 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $109,148 | $54,574 | — | — | 1 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $108,840 | $54,420 | — | — | 2 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $105,214 | $52,607 | — | — | 1 |
| J0584 | BUROSUMAB-TWZA 30 MG/ML SUBCUTANEOUS SOLUTION | $100,778 | $50,389 | — | — | 2 |
| J3263 | TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION | $99,930 | $49,965 | — | — | 1 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $98,163 | $49,081 | — | — | 1 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $91,805 | $45,903 | — | — | 1 |
| J2997 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $91,791 | $45,895 | — | — | 2 |
| J1930 | LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE | $87,161 | $43,581 | — | — | 1 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $79,718 | $39,859 | — | — | 1 |
| J9022 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $72,906 | $36,453 | — | — | 1 |
| J9210 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $71,833 | $35,916 | — | — | 2 |
| J9063 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION | $71,331 | $35,666 | — | — | 1 |
| J1323 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $69,940 | $34,970 | — | — | 4 |
| J9332 | EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION | $66,572 | $33,286 | — | — | 1 |
| J9333 | ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION | $65,876 | $32,938 | — | — | 2 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $63,140 | $31,570 | — | — | 1 |
| J1932 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $62,612 | $31,306 | — | — | 1 |
| J1299 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $60,388 | $30,194 | — | — | 1 |
| J0517 | BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE | $55,627 | $27,814 | — | — | 1 |
| J2267 | MIRIKIZUMAB-MRKZ 100 MG/ML SUBCUTANEOUS PEN INJECTOR | $54,058 | $27,029 | — | — | 2 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $53,534 | $26,767 | — | — | 3 |
| J9038 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $50,819 | $25,409 | — | — | 2 |
| J2506 | PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR | $48,332 | $24,166 | — | — | 1 |
| J3315 | TRIPTORELIN PAMOATE 22.5 MG IM SUSPENSION | $47,704 | $23,852 | — | — | 2 |
| J9227 | ISATUXIMAB-IRFC 20 MG/ML INTRAVENOUS SOLUTION | $44,427 | $22,214 | — | — | 2 |
| J9204 | MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION | $43,420 | $21,710 | — | — | 1 |
| J0739 | CABOTEGRAVIR ER 600 MG/3 ML (200 MG/ML) IM SUSPENSION,EXTENDED RELEASE | $43,296 | $21,648 | — | — | 3 |
| A9517 | SODIUM IODIDE-131 (I-131) 500 MCI/0.5 ML ORAL KIT (THERAPEUTIC) | $42,188 | $21,094 | — | — | 1 |
Showing top 50 of 14,988 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.